Levitz Michael L 4
4 · Anika Therapeutics, Inc. · Filed Aug 11, 2023
Insider Transaction Report
Form 4
Levitz Michael L
EVP, CFO, Treasurer
Transactions
- Tax Payment
Common Stock
2023-08-10$18.58/sh−1,133$21,051→ 33,232 total - Exercise/Conversion
Common Stock
2023-08-10+3,859→ 34,365 total - Exercise/Conversion
Restricted Stock Unit
2023-08-10−3,859→ 0 totalExercise: $0.00→ Common Stock (3,859 underlying)
Footnotes (5)
- [F1]Reflects the third and final vesting installment of Restricted Stock Units (RSUs) granted on August 10, 2020.
- [F2]Includes 668 shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan on May 12, 2023.
- [F3]Reflects an aggregate of 1,133 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on August 10, 2023.
- [F4]Reflects the closing price of ANIK common stock on August 10, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
- [F5]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning August 10, 2021.